A new study of nerve cells affected by Huntington’s disease (HD) reveals that the disease-causing gene slowly expands over ...

This year’s JP Morgan struck a different tone than previous years—a very pleasant one, despite higher security anxieties ...

One of the biggest stories of last year was Lykos Therapeutics’ failure to get its MDMA candidate over the finish line for ...

While medical device shortages are nothing new, the FDA said it is becoming more concerned that supply chain disruptions are ...

After six years at Apellis, Chief Operating Officer Adam Townsend is saying goodbye to take on his first CEO job. The veteran ...

Boehringer Ingelheim’s investigational schizophrenia candidate has failed to improve cognitive impairment or functioning in a ...

WuXi AppTec is parting ways with its U.S. medical device testing business, selling its two stateside locations to the ...

Notch Therapeutics is making “significant” layoffs to conserve its cash while the cell therapy biotech seeks out new partners ...

GE HealthCare is launching a new imaging research collaboration with the University of California, San Francisco, aimed at ...

In an early look at its annual earnings report, Guardant Health posted revenue gains of 31%—with the $737 million total ...

About 100 days into the CEO role at Kyverna Therapeutics, Warner Biddle has determined the strategic priorities for the ...

Serina Therapeutics is shedding a subsidiary to start the new year off debt-free. | Serina Therapeutics is shedding a ...